A device is provided for the self-administration of cannabinoids. The device includes a container having an opening on a first end thereof, a cap which releasably engages said first end of said container, and an assembly, including first and second modules, which is removably placed inside of the container. The first module includes a first element equipped with first and second threading, a receptacle for said solid medium, said receptacle being equipped with at least one surface feature which slidingly engages said first threading, and a solid medium which is seated in said receptacle and which contains at least one cannabinoid. The second module is equipped with a filter and has a first threading disposed on a first terminal portion thereof. Various accessories may be releasably attached to the container or assembly. Methods of using the device are also described.

A personal vapor inhaling unit is disclosed. An electronic flameless vapor inhaler unit that may simulate a cigarette has a cavity that receives a cartridge in the distal end of the inhaler unit. The cartridge brings a substance to be vaporized in contact with a wick. When the unit is activated, and the user provides suction, the substance to be vaporized is drawn out of the cartridge, through the wick, and is atomized by the wick into a cavity containing a heating element. The heating element vaporizes the atomized substance. The vapors then continue to be pulled by the user through a mouthpiece and mouthpiece cover where they may be inhaled.

A droplet delivery device includes a housing with a mouthpiece port or outlet from a nasal device for releasing fluid droplets, a fluid reservoir, and an ejector bracket having a membrane positioned between a mesh with a plurality of openings and a vibrating member that is coupled to an electronic transducer, such as an ultrasonic transducer. The transducer vibrates the vibrating member which causes the membrane to push fluid supplied by the reservoir through the mesh to generate droplets in an ejected stream released through the outlet.

The invention generally refers to a stainless steel can for use in a metered dose inhaler device, containing an aerosol formulation, comprising glycopyrronium bromide and formoterol, or a salt or a solvate thereof, optionally in combination with one or more additional active ingredient, endowed with a high stability.

Heat-not-burn articles are provided. In some embodiments, the heat-not-burn article may comprise: an inner core comprising at least one compressed rod of cannabis-based material; and an outer sheath comprising a sheet of plant-based material, the outer sheath receiving the inner core therein. The heat-not-burn articles may be heated without combustion to generate an inhalable aerosol and/or vapor, thereby reducing or eliminating undesirable byproducts typically associated with smoke. Also provided are related methods and systems for making a heat-not-burn article.

Systems and methods for monitoring accurate, real-time medicament device events, performing analytics on that data, and providing notifications are described. In various embodiments, an application server receives controller medication events, analyzes the events, associated event times, and controller medication dosage plans to characterize event times and send notifications for future doses. The controller medication dosage plan may specify a dose time for a planned dose, a narrow time window comprising the dose time, and an expanded time window comprising the narrow time window and longer in duration than the narrow time window, and the events may be characterized based on their time relative to the dose time, the time windows, and other events.

A medicine vaporizer apparatus comprises a base with an upwardly extending heating element disposed within a rigid tube. Air is drawn into the rigid tube through an aperture in the rigid tube below the heating element and directed over the heating element to then be drawn through a flexible tube and through a filter or screen comprising an amount of medicine. Heated air flows over the amount of medicine and vaporizes the same, wherein the medicine is thereafter drawn into the lungs of a patient pulling the air therethrough with his or her mouth. Thermal separation and cooling of various parts prevents accidental injury to users and provides an inert air path for the air therethrough. The apparatus further provides controlled incineration and/or vaporization of the medicine.

A steam inhaler includes a steam chamber housing having mounted therein a heater assembly. The steam chamber housing defines a steam chamber adapted to receive water. A fitting mounted to the steam chamber housing has a steam conduit section extended toward an exterior vent opening, a nozzle conduit section extended from the steam conduit, and a fresh air conduit section extended from the steam conduit section at a location downstream of the nozzle conduit section. The fitting is configured such that steam flows freely from the steam chamber, through the steam conduit section toward the exterior vent opening, a suction provided at the nozzle redirects at least a portion of the steam into the nozzle conduit section toward a mask, and the fresh air conduit directs fresh air into the steam conduit section to reduce a temperature of the steam exiting the exterior vent opening.

A Non-Rebreather Exhalation Filtration Device (FD) with a front plastic sheet (PS), an aerosol separator (AS) and optionally a collection reservoir (R) may be fitted (i) (FIG. 3A) by its inlet port (IP) onto a nebulizer exhaust tube (NET), or (ii) by an adhesive layer (AL) onto a respiratory mask (M) having a port (P) and a flat surface (FIG. 5), or (iii) by an adhesive layer (AL) and flexible substrate (FS) onto a respiratory mask (M) having a port (P) and a non-flat (FIG. 6) surface. A deflector (D), stiffener component (SC) and rear plastic sheet (PS2) are disclosed. Methods of using the Filtration Device are disclosed.

The present invention relates to a device for delivering acetylsalicylic acid or a salt thereof for the administration thereof through oral inhalation route for the preventive or curative treatment of thrombohemolytic events, in particular for myocardial infarction.